G42 Healthcare is committed to developing a world-class, sustainable healthcare sector in the UAE and wider region. At the forefront in the battle against the pandemic, G42 Healthcare partnered with Abu Dhabi authorities to develop a massive throughput laboratory in 14 days and spearheaded the world’s first Phase 3 clinical trial of COVID-19 inactivated vaccine. Beyond Covid-19, G42 Healthcare is also developing a program of activities to support the health of future generations – ranging from population genomics, imaging and diagnostics to digitization programs, manufacturing and cutting-edge research.